PropertyValue
?:creator
?:doi
  • 10.1007/s15006-020-4543-0
?:doi
?:externalLink
?:journal
  • MMW_Fortschr_Med
?:license
  • no-cc
?:pmcid
?:publication_isRelatedTo_Disease
?:source
  • PMC
?:title
  • Neuraminidasehemmer in der Praxis - wer profitiert?
?:type
?:year
  • 2020-11-12

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ar5xygx8>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ar5xygx8>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all